Kopran Limited Share Price & Analysis
₹252.45+1.26%Updated 28 Oct 2026, 03:30 pm IST
LTP
₹252.45+1.26%Open
₹248.50High
₹260.20Low
₹246.15Close
₹252.4552W High
₹296.0052W Low
₹107.00Volume
323KLot Size
1Sector
HealthcareMarket Cap
₹1K CrFace Value
₹10Small Cap
Price Chart
Candle
Range
Fundamentals
P/E
54.50Sector P/E
50.20P/B
—EPS
₹3.43ROE
4.91%ROCE
6.65%D/E Ratio
0.29Div Yield
1.06%Book Value
₹110.00Strengths
- Low debt relative to equity (D/E 0.3x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
KOPRAN · as of Mar 2026
Promoters44.42%0.03pp
FII1.11%0.25pp
Public54.45%0.23pp
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 44.49% | 44.49% | 44.49% | 44.49% | 44.45% | 44.42% |
| FII | 0.48% | 0.84% | 0.68% | 1.31% | 0.86% | 1.11% |
| DII | 0.14% | 1.20% | 0.14% | 0.22% | — | — |
| Public | 54.88% | 53.47% | 54.68% | 53.98% | 54.68% | 54.45% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend18 May 2026
Dividend - Rs 3 Per Share
Dividend3 Sept 2025
Annual General Meeting/Dividend - Rs 3 Per Share
Dividend1 Sept 2024
Annual General Meeting/Dividend - Rs 3 Per Share
Dividend6 Sept 2023
Latest News
All newsKopran sees spurt in trading volume; NSE seeks disclosure
*Kopran sees spurt in trading volume; NSE seeks disclosure*. The NSE flagged a significant increase in trading volume in Kopran Limited and sought updated information to safeguard investor interests. The company has since submitted its response to the exchange. No specific financial figures or material events were disclosed. 📊 *STOCKS:* KOPRAN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #VolumeSpurt
NSE Filing1 Sept
Kopran's EU GMP inspection at Khopoli facility closes.
*Kopran's EU GMP inspection at Khopoli facility closes.* The Medicine Authority of the European Union completed its Good Manufacturing Practice audit at Kopran’s formulation plant. Closure indicates no immediate regulatory concerns. This is a routine compliance update with no financial impact. 📊 *STOCKS:* $KOPRAN | 🏢 *SECTOR:* Pharma | #LOWIMPACT #GMP
NSE Filing6d ago
Kopran shares rise on newspaper publication notice
*Kopran shares see activity following newspaper publication notice.* The filing indicates routine corporate disclosure as per regulatory norms. No financial figures or strategic updates were provided. Such notices typically precede shareholder communications or compliance requirements. 📊 *STOCKS:* KOPRAN | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling
NSE Filing10 Aug
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹194 Cr 64.4% | ₹118 Cr 12.6% | ₹135 Cr 21.5% | ₹172 Cr 3.6% | ₹166 Cr 9.2% | ₹152 Cr 9.4% | ₹139 Cr 25.3% | ₹186.08 Cr |
| Op. Profit | ₹18 Cr 460.0% | ₹-5 Cr 135.7% | ₹14 Cr 17.6% | ₹17 Cr 15.0% | ₹20 Cr 33.3% | ₹15 Cr 16.7% | ₹18 Cr 17.0% | ₹21.69 Cr |
| OPM | 9.0% 325.0% | -4.0% 140.0% | 10.0% 0.0% | 10.0% 16.7% | 12.0% 20.0% | 10.0% 23.1% | 13.0% 11.5% | 11.7% |
| Net Profit | ₹9 Cr 190.0% | ₹-10 Cr 242.9% | ₹7 Cr 30.0% | ₹10 Cr 0.0% | ₹10 Cr 42.9% | ₹7 Cr 36.4% | ₹11 Cr 40.9% | ₹18.62 Cr |
| EPS (₹) | 1.94 194.2% | -2.06 233.8% | 1.54 23.4% | 2.01 6.9% | 2.16 41.2% | 1.53 33.5% | 2.3 40.4% | 3.86 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹681 Cr 8.1% | ₹630 Cr 2.4% | ₹615 Cr 11.6% | ₹551 Cr 15.3% | ₹478 Cr 2.8% | ₹492 Cr 36.7% | ₹360 Cr 0.6% | ₹358 Cr 14.4% | ₹313 Cr 1.0% | ₹310 Cr |
| Expenses | ₹619 Cr 11.1% | ₹557 Cr 3.1% | ₹540 Cr 8.2% | ₹499 Cr 27.9% | ₹390 Cr 4.9% | ₹410 Cr 31.0% | ₹313 Cr 0.3% | ₹312 Cr 10.2% | ₹283 Cr 3.3% | ₹274 Cr |
| Op. Profit | ₹62 Cr 15.1% | ₹73 Cr 1.4% | ₹74 Cr 42.3% | ₹52 Cr 40.2% | ₹87 Cr 6.1% | ₹82 Cr 74.5% | ₹47 Cr 2.2% | ₹46 Cr 48.4% | ₹31 Cr 13.9% | ₹36 Cr |
| OPM | 9.0% 25.0% | 12.0% 0.0% | 12.0% 33.3% | 9.0% 50.0% | 18.0% 5.9% | 17.0% 30.8% | 13.0% 0.0% | 13.0% 30.0% | 10.0% 16.7% | 12.0% |
| Other Income | ₹0 Cr 100.0% | ₹4 Cr 73.3% | ₹15 Cr 400.0% | ₹3 Cr 72.7% | ₹11 Cr 38.9% | ₹18 Cr | ₹0 Cr 100.0% | ₹3 Cr 66.7% | ₹9 Cr 18.2% | ₹11 Cr |
| Interest | ₹10 Cr 11.1% | ₹9 Cr 0.0% | ₹9 Cr 50.0% | ₹6 Cr 20.0% | ₹5 Cr 16.7% | ₹6 Cr 33.3% | ₹9 Cr 0.0% | ₹9 Cr 0.0% | ₹9 Cr 35.7% | ₹14 Cr |
| Depreciation | ₹17 Cr 6.3% | ₹16 Cr 23.1% | ₹13 Cr 0.0% | ₹13 Cr 18.2% | ₹11 Cr 10.0% | ₹10 Cr 0.0% | ₹10 Cr 11.1% | ₹9 Cr 0.0% | ₹9 Cr 12.5% | ₹8 Cr |
| PBT | ₹34 Cr 34.6% | ₹52 Cr 23.5% | ₹68 Cr 88.9% | ₹36 Cr 56.1% | ₹82 Cr 1.2% | ₹83 Cr 196.4% | ₹28 Cr 12.5% | ₹32 Cr 39.1% | ₹23 Cr 8.0% | ₹25 Cr |
| Tax % | 25.0% 3.8% | 26.0% 4.0% | 25.0% 4.2% | 24.0% 4.0% | 25.0% 3.8% | 26.0% 0.0% | 26.0% 8.3% | 24.0% 140.0% | 10.0% 50.0% | 20.0% |
| Net Profit | ₹26 Cr 33.3% | ₹39 Cr 23.5% | ₹51 Cr 88.9% | ₹27 Cr 55.7% | ₹61 Cr 1.6% | ₹62 Cr 195.2% | ₹21 Cr 12.5% | ₹24 Cr 20.0% | ₹20 Cr 0.0% | ₹20 Cr |
| EPS (₹) | 5.33 33.3% | 7.99 24.4% | 10.57 87.1% | 5.65 55.4% | 12.66 11.1% | 14.24 193.0% | 4.86 12.4% | 5.55 17.1% | 4.74 3.0% | 4.6 |
| Div Payout | 0.0% 100.0% | 38.0% 35.7% | 28.0% 47.2% | 53.0% 120.8% | 24.0% 14.3% | 21.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||||
| Equity Capital | ₹48 Cr 0.0% | ₹48 Cr 0.0% | ₹48 Cr 0.0% | ₹48 Cr 0.0% | ₹48 Cr 11.6% | ₹43 Cr 0.0% | ₹43 Cr 0.0% | ₹43 Cr 0.0% | ₹43 Cr 0.0% | ₹43 Cr |
| Reserves | ₹453 Cr 3.6% | ₹470 Cr 6.1% | ₹443 Cr 13.3% | ₹391 Cr 3.4% | ₹378 Cr 87.1% | ₹202 Cr 38.4% | ₹146 Cr 16.8% | ₹125 Cr 23.8% | ₹101 Cr 24.7% | ₹81 Cr |
| Borrowings | ₹157 Cr 6.1% | ₹148 Cr 49.5% | ₹99 Cr 32.0% | ₹75 Cr 0.0% | ₹75 Cr 13.6% | ₹66 Cr 25.0% | ₹88 Cr 9.3% | ₹97 Cr 9.0% | ₹89 Cr 6.3% | ₹95 Cr |
| Other Liabilities | ₹155 Cr 12.9% | ₹178 Cr 16.3% | ₹153 Cr 13.3% | ₹135 Cr 22.7% | ₹110 Cr 14.1% | ₹128 Cr 39.1% | ₹92 Cr 8.2% | ₹85 Cr 3.7% | ₹82 Cr 5.1% | ₹78 Cr |
| Total Liabilities | ₹813 Cr 3.7% | ₹844 Cr 13.6% | ₹743 Cr 14.3% | ₹650 Cr 6.4% | ₹611 Cr 39.2% | ₹439 Cr 18.6% | ₹370 Cr 5.4% | ₹351 Cr 11.4% | ₹315 Cr 5.7% | ₹298 Cr |
Assets | ||||||||||
| Fixed Assets | ₹235 Cr 13.0% | ₹208 Cr 14.3% | ₹182 Cr 10.3% | ₹165 Cr 9.3% | ₹151 Cr 34.8% | ₹112 Cr 0.9% | ₹111 Cr 1.8% | ₹113 Cr 8.7% | ₹104 Cr 0.0% | ₹104 Cr |
| CWIP | ₹114 Cr 0.9% | ₹113 Cr 16.5% | ₹97 Cr 38.6% | ₹70 Cr 94.4% | ₹36 Cr 16.3% | ₹43 Cr 43.3% | ₹30 Cr 25.0% | ₹24 Cr 140.0% | ₹10 Cr 66.7% | ₹6 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹465 Cr 10.9% | ₹522 Cr 12.3% | ₹465 Cr 12.0% | ₹415 Cr 2.4% | ₹425 Cr 49.6% | ₹284 Cr 24.0% | ₹229 Cr 7.0% | ₹214 Cr 6.5% | ₹201 Cr 7.5% | ₹187 Cr |
| Total Assets | ₹813 Cr 3.7% | ₹844 Cr 13.6% | ₹743 Cr 14.3% | ₹650 Cr 6.4% | ₹611 Cr 39.2% | ₹439 Cr 18.6% | ₹370 Cr 5.4% | ₹351 Cr 11.4% | ₹315 Cr 5.7% | ₹298 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹42 Cr 2.3% | ₹43 Cr 26.5% | ₹34 Cr 203.0% | ₹-33 Cr 155.0% | ₹60 Cr 93.5% | ₹31 Cr 24.0% | ₹25 Cr 3.8% | ₹26 Cr 62.5% | ₹16 Cr 44.8% | ₹29 Cr |
| Investing CF | ₹-56 Cr 27.3% | ₹-44 Cr 238.5% | ₹-13 Cr 84.5% | ₹-84 Cr 236.0% | ₹-25 Cr 92.3% | ₹-13 Cr 48.0% | ₹-25 Cr 127.3% | ₹-11 Cr 38.9% | ₹-18 Cr 100.0% | ₹-9 Cr |
| Financing CF | ₹26 Cr 2500.0% | ₹1 Cr 105.0% | ₹-20 Cr 116.3% | ₹123 Cr 451.4% | ₹-35 Cr 94.4% | ₹-18 Cr 1700.0% | ₹-1 Cr 93.3% | ₹-15 Cr 850.0% | ₹2 Cr 110.5% | ₹-19 Cr |
| Net Cash Flow | ₹11 Cr 1000.0% | ₹1 Cr 50.0% | ₹2 Cr 60.0% | ₹5 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹-17 Cr 30.8% | ₹-13 Cr 51.9% | ₹-27 Cr 64.5% | ₹-76 Cr 276.7% | ₹43 Cr 152.9% | ₹17 Cr 383.3% | ₹-6 Cr 142.9% | ₹14 Cr | ₹0 Cr 100.0% | ₹18 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 125d 0.8% | 126d 16.7% | 108d 11.3% | 97d 9.0% | 89d 5.3% | 94d 6.8% | 88d 17.3% | 75d 12.8% | 86d 22.9% | 70d |
| Inventory Days | 153d 21.4% | 126d 5.3% | 133d 34.2% | 202d 66.9% | 121d 21.4% | 154d 19.4% | 129d 6.5% | 138d 13.1% | 122d 2.5% | 119d |
| Days Payable | 108d 4.9% | 103d 15.7% | 89d 6.0% | 84d 19.2% | 104d 9.5% | 95d 5.6% | 90d 23.7% | 118d 24.2% | 95d 17.4% | 115d |
| Cash Conv. Cycle | 170d 14.1% | 149d 2.0% | 152d 29.3% | 215d 102.8% | 106d 30.7% | 153d 20.5% | 127d 32.3% | 96d 15.0% | 113d 52.7% | 74d |
| Working Capital Days | 113d 13.7% | 131d 5.8% | 139d 12.0% | 158d 95.1% | 81d 2.5% | 79d 12.9% | 70d 16.7% | 60d 39.5% | 43d 26.5% | 34d |
| ROCE | 10.0% 28.6% | 14.0% 75.0% | 8.0% 61.9% | 21.0% 30.0% | 30.0% 114.3% | 14.0% 12.5% | 16.0% 14.3% | 14.0% 26.3% | 19.0% 35.7% | 14.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Kopran Limited share price today?
Kopran Limited (KOPRAN) is currently trading at ₹252.45 on NSE, up 1.26% as of the last market session. Prices update daily after market close on MarketNetra.
Is Kopran Limited available in F&O (Futures & Options)?
Yes, Kopran Limited (KOPRAN) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Kopran Limited 52-week high and low?
Kopran Limited's 52-week high is ₹296 and the 52-week low is ₹107. The current price of ₹252.45 is 14.7% below the 52W high.
What is Kopran Limited P/E ratio?
Kopran Limited's current P/E ratio is 54.5. This indicates the market is paying ₹54.5 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Kopran Limited options?
Kopran Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade KOPRAN options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.